Prelude Capital Management, LLC Amicus Therapeutics, Inc. Transaction History

Prelude Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $130,606 - $165,452	-13,300 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $150,953 - $391,494	-16,408 Reduced 55.23%	13,300 $131,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $72,037 - $133,111	-5,348 Reduced 15.26%	29,708 $686,000
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $98,170 - $121,018	-7,616 Reduced 17.85%	35,056 $495,000
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $378,073 - $669,523	42,672 New	42,672 $643,000

Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $13,613 - $19,565	-1,820 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $14,596 - $24,115	1,820 New	1,820 $15,000
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $6,400 - $8,409	-584 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $1.58 Million - $2.2 Million	-157,697 Reduced 99.63%	584 $8,000
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $930,320 - $1.33 Million	80,200 Added 102.71%	158,281 $1.91 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $651,484 - $847,971	-49,618 Reduced 38.86%	78,081 $1.22 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $1.08 Million - $1.35 Million	78,851 Added 161.42%	127,699 $1.92 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $299,639 - $388,980	-23,952 Reduced 32.9%	48,848 $703,000
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $854,672 - $1.15 Million	72,800	72,800 $1.1 Million

273

325M

841K

353K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.76B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.